معرفی
David Ian Quinn is a Clinical Professor of Medicine at the Keck School of Medicine of the University of Southern California. He serves as Medical Director of the Norris Cancer Hospital and Clinics and leads the Developmental Therapeutics Program at the USC Norris Comprehensive Cancer Center. Dr. Quinn is internationally recognized for his expertise in clinical trials and molecular correlative studies in genitourinary cancers, particularly focusing on prostate cancer, renal cell carcinoma, and urothelial cancer.
His research explores immunotherapy combinations, targeted molecular agents, and biomarker development to improve outcomes in advanced cancers. Recent publications highlight investigations into novel drug combinations (e.g., enzalutamide + radium-223; pembrolizumab + vorinostat), circulating tumor cell analysis, and bone metabolism markers for prognostication.
- Editorial Roles: American Journal of Clinical Oncology, cancer.net (ASCO), Clinical Genitourinary Cancer, Annals of Oncology
- Leadership: NCI Prostate Cancer Task Force, California Cancer Consortium (Co-Chair), SWOG Organ Site Chair for Prostate Cancer
Dr. Quinn has contributed to over 200 peer-reviewed publications and is a sought-after speaker in more than 40 countries. He actively participates in clinical trial design and real-world cancer data analysis through initiatives like the TRUMPET Registry.
